DAYTIME HYPERTENSION AND THE EFFECTS OF SHORT-TERM NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT IN OBSTRUCTIVE SLEEP-APNEA SYNDROME

被引：32

作者：

AKASHIBA, T

KURASHINA, K

MINEMURA, H

YAMAMOTO, H

HORIE, T

机构：

[1] First Department of Internal Medicine, Nihon University, School of Medicine, Tokyo

来源：

INTERNAL MEDICINE | 1995年 / 34卷 / 06期

关键词：

OBSTRUCTIVE SLEEP APNEA SYNDROME; CONTINUOUS POSITIVE AIRWAY PRESSURE; DAYTIME HYPERTENSION;

D O I：

10.2169/internalmedicine.34.528

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Daytime blood pressure (BP) in 31 male patients with obstructive sleep apnea syndrome (OSAS) was measured and the effects of nasal continuous positive airway pressure (CPAP) treatment on daytime BP were studied. Subjects were 48+/-10 (mean+/-SD) years old and weighed 80+/-13 kg, The mean systolic BP and diastolic BP were 135+/-15 mmHg and 88+/-14 mmHg, respectively and daytime hypertension was present in 12 (38 %) subjects, Apnea index (AI) and the lowest oxygen saturation during sleep were significantly more severe in the hypertensive (HT) than in the non-hypertensive (NHT) patients (p<0.05). AI was significantly correlated with diastolic BP (p<0.05) and the mean and lowest oxygen saturation during sleep were significantly correlated with both systolic (p<0.05) and diastolic BP (p<0.01). After nasal CPAP treatment for two weeks, both systolic and diastolic BP were significantly reduced; the former from 135+/-15 mmHg to 126+/-10 mmHg (p<0.005) and the latter from 88+/-14 mmHg to 78+/-6 mmHg (p<0.001), These data form direct evidence that daytime hypertension is partially induced by OSAS and is reversible with nasal CPAP treatment.

引用

页码：528 / 532

页数：5

共 29 条

[1]

Lavia P., Ben-Yosef R., Rubin A.E., Prevalence of sleep apnea syndrome among patients with essential hypertension, Am Heart J, 108, (1984)

[2]

Kales A., Bixler E.O., Cadieux R.J., Et al., Sleep apnea in a hypertensive population, Lancet, 2, (1984)

[3]

Fletcher E.C., DeVehnke R.D., Lovoi M.S., Gorin A.B., Undiagnosed sleep apnea in patients with essential hypertension, Ann Intern Med, 103, (1985)

[4]

Tilkian A.G., Guilleminault C., Schroeder J.S., Et al., Hemodynamics in sleep-induced apnea, Ann Intern Med, 85, (1976)

[5]

Motta H., Guilleminault C., Schroeder J.S., Dement W.C., Tracheostomy and hemodynamic changes in sleep-induced apnea, Ann Intern Med, 89, (1978)

[6]

Guilleminault C., Simmons F.B., Motta H., Et al., Obstructive sleep apnea syndrome and tracheostomy: long-term follow-up experience, Arch Intern Med, 141, (1981)

[7]

Burack B., The hypersomnia-sleep apnea syndrome: its recognition in clinical cardiology, Am Heart J, 107, (1984)

[8]

Shepard J.W., Garrison M.W., Grither D.A., Dolan G.F., Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea, Chest, 88, (1985)

[9]

Partinen M., Jamieson A., Guilleminault C., Long-term outcome for obstructive sleep apnea syndrome patients, Chest, 94, (1988)

[10]

Millman R.P., Redline S., Carlisle B.A., Assaf A.R., Levinson P.D., Daytime hypertension in obstructive sleep apnea, Chest, 99, (1991)

← 1 2 3 →